The 7th International Conference on Retroviral Integration

Dear Colleagues,

Integration is the hallmark step of retroviral replication and forms the basis of the latent HIV reservoir that persists in the face of aggressive treatment with antiretroviral inhibitors. HIV cure research accordingly looks to activate latently infected cells for immune clearance or place them in a state of deep sleep to effect a functional cure. This Special Issue will summarize the talks presented at the 7^th International Conference on Retroviral Integration (http://www.retrointegration2023.org/), which will take place in Boulder, Colorado, during the summer of 2023 (July 31 to August 4). In addition to the relationship between sites of integration and HIV latency, the meeting will encompass other subjects topical to integrase and integration research, which include the following:

• Structure and function of retroviral intasomes;
• Cellular partners of HIV-1 integrase;
• Retroviral vectors for human genetic therapy;
• Integrase strand transfer inhibitors and drug resistance mechanisms;
• Allosteric integrase inhibitors and drug resistance mechanisms;
• Preintegration complex structure and function;
• Nuclear import of HIV-1 cores/preintegration complexes;
• Orthologous systems (retrotransposons; DNA transposons).

Prof. Dr. Alan N. Engelman
Prof. Dr. Mamuka Kvaratskhelia
Prof. Dr. Duane P. Grandgenett
Dr. Goedele N. Maertens
Dr. Kristine Yoder
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.